|
|
|
| Phase I |
|
|
|
For over a decade, SIRO has helped the critical transition of a drug from preclinical studies to clinical trials. This is a vital step in the drug development process as many licensing deals in the pharmaceutical/ biotech sector occur during this stage. The value of a potential drug increases dramatically with a successful demonstration of safety and efficacy in the human population.
At this stage it is critical that you work with a partner that delivers timely, accurate data to enable you to make decisions about the safety and efficacy of your compound early in the clinical development cycle. The Phase I group at SIRO has worked with many emerging global pharmaceutical and biotech companies to guide potential drug candidates into First-in-Human trials and Proof-of-Concept studies. The group also maintains relationships with specialized Phase I units across the country.
Our services include
Phase I Studies in Oncology/DM
Project management
Feasibility and risk assessments
Site selection and prequalification
Clinical and medical monitoring
Site management
Recruitment support
Training for the project team
Protocol and CRF development
Phase I Project Management and Medical Services Experience:
Oncology
Lung cancer Study
Solid malignant tumors
Glioblastoma
Breast Cancer
Multiple Myeloma
Gastric cancer
Respiratory
COPD
Ophthalmology
Macular edema
Urology
Overactive bladder
Neuropathic Bladder
Tropical Diseases
Kala Azar
|
|
|
|
